Zimbabwe clears way for cannabis-based medical products
Zimbabwe has cleared the way for cannabis-based medical products to be sold for the first time as the southern African country eyes the industry valued at Sh148.5 billion ($1.25 billion).
The Medicines Control of Zimbabwe (MCZ) has opened applications for cannabis and hemp producers, manufacturers, importers, exporters and retail pharmacists.
The debt-ridden nation became one of the first African countries to legalise cannabis in 2018 but little has been done since to permit commercial production of the drug.
Comments